About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Kringle Pharma,Inc.(4884) Financial Results

4884
TSE Growth
Kringle Pharma,Inc.
809
JPY
-1
(-0.12%)
Dec 23, 3:30 pm JST
5.16
USD
Dec 23, 1:30 am EST
Result
PTS
outside of trading hours
794
Dec 23, 10:30 pm JST
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2021 289 -357 -299 -301 -72.5 0 Nov 12, 2021 J-GAAP
Sep, 2022 391 -426 -330 -331 -68.3 0 Nov 14, 2022 J-GAAP
Sep, 2023 69 -888 -852 -854 -158.5 0 Nov 13, 2023 J-GAAP
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
Sep, 2025 Guidance 272 -1,379 -1,379 -1,380 -202.6 0 Nov 13, 2024 J-GAAP
YoY +240.0% -68.8% -82.9% -82.5% -71.4%
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 467 -171 101 100 96.3
Fiscal Year Sep, 2020 Sep, 2020 Sep, 2016 Sep, 2016 Sep, 2016
First Half
Result
Guidance History
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2021 27 -310 -318 -319 -70.2 0 May 13, 2022 J-GAAP
Oct - Mar, 2022 34 -314 -314 -315 -58.6 0 May 15, 2023 J-GAAP
Oct - Mar, 2023 43 -366 -365 -366 -60.2 0 May 13, 2024 J-GAAP
Oct - Mar, 2024 Guidance ー ー ー ー － 0 Nov 13, 2024 J-GAAP
YoY － － － － －
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Sep, 2022 -426 -239 15 -254 603 2,502 77.99 J-GAAP
Sep, 2023 -888 -809 -689 -120 69 1,761 67.27 J-GAAP
Sep, 2024 -817 -782 -661 -121 838 1,816 65.87 J-GAAP
Actual Performance and Financial Trends
Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2022 391 -426 -330 -331 -68.3 0 Nov 14, 2022 J-GAAP
Sep, 2023 69 -888 -852 -854 -158.5 0 Nov 13, 2023 J-GAAP
Sep, 2024 80 -817 -754 -756 -118.2 0 Nov 13, 2024 J-GAAP
YoY +15.9% +8.0% +11.5% +11.5% +25.4%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 17 -157 -157 -157 -29.3 -923.5 Feb 10, 2023 J-GAAP
Jan - Mar, 2023 17 -157 -157 -158 -29.4 -923.5 May 15, 2023 J-GAAP
Apr - Jun, 2023 17 -306 -263 -263 -48.9 -1,800.0 Aug 14, 2023 J-GAAP
Jul - Sep, 2023 18 -268 -275 -276 -51.2 -1,488.9 Nov 13, 2023 J-GAAP
Oct - Dec, 2023 18 -168 -169 -169 -29.5 -933.3 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 25 -198 -196 -197 -32.4 -792.0 May 13, 2024 J-GAAP
Apr - Jun, 2024 18 -213 -152 -152 -24.3 -1,183.3 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 19 -238 -237 -238 -37.2 -1,252.6 Nov 13, 2024 J-GAAP
YoY +5.6% +11.2% +13.8% +13.8% +27.3%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 406 51 50 50 45.6
Fiscal Year Sep, 2020 Sep, 2020 Sep, 2020 Sep, 2020 Sep, 2020
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Sep, 2022 517.75 86.8 3,208 2,785 -331 ー Nov 14, 2022 J-GAAP
Sep, 2023 363.45 76.7 2,618 2,007 -1,185 ー Nov 13, 2023 J-GAAP
Sep, 2024 306.87 75.8 2,757 2,089 -756 ー Nov 13, 2024 J-GAAP